Aptamer Group PLC

APTA

Equity

ISIN GB00BNRRP542 / Valor 115383974

LSE London Stock Exchange, SETS (2024-09-16)

GBP 0.0024+0.64%

Aptamer Group PLC
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

d development timeline, high specificity, and stability, making them ideal for a wide range of applications in the life sciences industry. Aptamer Group PLC is a biotechnology company that specializes in the development of custom Optimer® solutions, diagnostics, and therapeutics. The company's proprietary platform technology has enabled it to work with global pharmaceutical companies, diagnostic development firms, and research institutes to create custom projects and establish royalty-bearing licenses. With a focus on generating revenue through custom projects in the near-term and creating long-term value through diagnostic and therapeutic development, Aptamer Group PLC aims to support discovery and development in the life sciences industry by providing faster, more informed decision-making tools for scientists and collaborators.

Summarized from source with an LLMView SourceSector: Technology

Revenue Decline

Aptamer Group PLC reported a significant decline in revenue for the six months ended 31 December 2023. The revenue for this period was £0.3 million, compared to £1.0 million in the same period of the previous year. This decrease highlights the challenges the company faced in maintaining its sales momentum.

Cash Balance

As of 31 December 2023, Aptamer Group PLC had a cash balance of £1.8 million. This is a slight decrease from the £1.9 million reported at the end of the same period in the previous year. The company has managed to maintain a relatively stable cash position despite the revenue drop.

Adjusted EBITDA Loss

The adjusted EBITDA loss for Aptamer Group PLC in the six months ended 31 December 2023 was £1.8 million. This is an improvement from the £2.5 million loss reported in the same period of the previous year. The reduction in losses indicates some progress in cost management and operational efficiency.

Equity Placings

During the reporting period, Aptamer Group PLC successfully recapitalised with £3.5 million raised through two equity placings. This fundraising effort has provided the company with additional financial resources to support its ongoing operations and strategic initiatives.

Cost Base Reset

In September 2023, Aptamer Group PLC completed a reset of its fixed cost base to £3.5 million per annum. This restructuring was aimed at reducing operational costs while maintaining the company's ability to win sales and deliver projects. The cost base reset is expected to improve the company's financial stability moving forward.

Summarized from source with an LLMView Source

Key figures

-80.9%1Y

%3Y

%5Y

Performance

125%1Y

151%3Y

151%5Y

Volatility